BR9908273A - Formulações - Google Patents

Formulações

Info

Publication number
BR9908273A
BR9908273A BR9908273-0A BR9908273A BR9908273A BR 9908273 A BR9908273 A BR 9908273A BR 9908273 A BR9908273 A BR 9908273A BR 9908273 A BR9908273 A BR 9908273A
Authority
BR
Brazil
Prior art keywords
formulations
oxaliplatin
stabilizing
preparing
processes
Prior art date
Application number
BR9908273-0A
Other languages
English (en)
Inventor
Nicholas H Anderson
Stephen Brown
David A England
Ross Blundell
Martin R Gray
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10827600&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR9908273(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Publication of BR9908273A publication Critical patent/BR9908273A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/282—Platinum compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

Patente de Invenção:<B>"FORMULAçõES"<D>. A invenção refere-se a formulações em solução de oxaliplatina farmaceuticamente estáveis, ao método de uso delas no tratamento de tumores de câncer, aos processos para a preparação dessas formulações, e a um método para estabilizar as soluções de oxaliplatina.
BR9908273-0A 1998-02-25 1999-02-25 Formulações BR9908273A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9804013.2A GB9804013D0 (en) 1998-02-25 1998-02-25 Formulations
PCT/GB1999/000572 WO1999043355A2 (en) 1998-02-25 1999-02-25 Formulations containing oxaliplatin

Publications (1)

Publication Number Publication Date
BR9908273A true BR9908273A (pt) 2000-10-24

Family

ID=10827600

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9908273-0A BR9908273A (pt) 1998-02-25 1999-02-25 Formulações

Country Status (28)

Country Link
US (1) US6306902B1 (pt)
EP (1) EP0943331B1 (pt)
JP (1) JP4430229B2 (pt)
KR (1) KR20010041182A (pt)
CN (1) CN1152718C (pt)
AR (1) AR015524A1 (pt)
AT (1) ATE202472T1 (pt)
AU (1) AU757101B2 (pt)
BR (1) BR9908273A (pt)
CA (1) CA2261500C (pt)
CZ (1) CZ302196B6 (pt)
DE (1) DE69900162T2 (pt)
DK (1) DK0943331T3 (pt)
ES (1) ES2161085T3 (pt)
GB (1) GB9804013D0 (pt)
GR (1) GR3036646T3 (pt)
GT (1) GT199900019A (pt)
HK (1) HK1036405A1 (pt)
HU (1) HU224611B1 (pt)
IL (1) IL137772A (pt)
MX (1) MXPA00008195A (pt)
NO (1) NO329900B1 (pt)
PL (1) PL197948B1 (pt)
PT (1) PT943331E (pt)
RU (1) RU2207857C2 (pt)
UA (1) UA70316C2 (pt)
WO (1) WO1999043355A2 (pt)
ZA (1) ZA991489B (pt)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9804013D0 (en) 1998-02-25 1998-04-22 Sanofi Sa Formulations
PT1121117E (pt) * 1998-10-14 2002-10-31 Debiopharm Sa Acondicionamento de uma preparacao de oxaliplatina
ATE249825T1 (de) * 1999-08-30 2003-10-15 Debiopharm Sa Oxaliplatinhaltige parenteral anzuwendende stabilisierte arzneizubereitung und verfahren zu deren herstellung
US7070796B1 (en) 1999-08-30 2006-07-04 Debiopharm S.A. Pharmaceutically stable oxaliplatinum preparation for parenteral administration
AU2002223013A1 (en) * 2000-12-12 2002-06-24 Debiopharm S.A. Pharmaceutical oxaliplatinum preparation for parenteral administration and method for obtaining same
ATE365037T1 (de) 2001-03-02 2007-07-15 Debiopharm Sa Verwendung eines eine oxaliplatinlösung beinhaltenden fläschchens
US20040186172A1 (en) 2001-07-02 2004-09-23 Houssam Ibrahim Oxaliplatin active substance with a very low content of oxalic acid
US6476068B1 (en) * 2001-12-06 2002-11-05 Pharmacia Italia, S.P.A. Platinum derivative pharmaceutical formulations
CA2388352A1 (en) * 2002-05-31 2003-11-30 Voiceage Corporation A method and device for frequency-selective pitch enhancement of synthesized speed
DE10314377A1 (de) * 2003-03-28 2004-10-07 Stada Arzneimittel Ag Gebrauchsfertige Oxaliplatin-Lösungen
US20050020556A1 (en) * 2003-05-30 2005-01-27 Kosan Biosciences, Inc. Method for treating diseases using HSP90-inhibiting agents in combination with platinum coordination complexes
GB2441445B (en) * 2003-08-28 2008-04-23 Mayne Pharma Ltd Acid containing oxaliplatin formulation
US20050090544A1 (en) * 2003-08-28 2005-04-28 Whittaker Darryl V. Oxaliplatin formulations
JP2007504177A (ja) * 2003-09-02 2007-03-01 プリヴァ−ラケマ，エー．エス． 医薬組成物、その製造方法及び治療上の使用
CZ300795B6 (cs) * 2003-09-02 2009-08-12 Pliva-Lachema A. S. Farmaceutická kompozice a zpusob její výroby
US7576126B2 (en) 2003-11-25 2009-08-18 Platco Technologies (Proprietary) Limited Platinum (II) complexes, preparation and use
CN100471493C (zh) * 2003-12-17 2009-03-25 梅比欧法姆股份有限公司 含有奥沙利铂的脂质体制剂
WO2005102312A1 (en) * 2004-04-27 2005-11-03 Mayne Pharma Limited Concentrated oxaliplatin solutions
SI1789427T1 (sl) 2004-09-01 2009-10-31 Platco Technologies Proprietar Priprava kompleksov platine(II)
US20060063833A1 (en) * 2004-09-22 2006-03-23 Edgar Schridde Ready-to-use oxaliplatin solutions
US20060063720A1 (en) * 2004-09-22 2006-03-23 Edgar Schridde Oxaliplatin solution concentrate
DE102004052877B4 (de) * 2004-11-02 2008-06-19 Ebewe Pharma Ges.M.B.H. Nfg.Kg Stabile wässrige Formulierungen eines Platin-Derivats
DE102004063764A1 (de) * 2004-12-29 2006-07-13 Hexal Ag Kunststoff-Flasche für Oxaliplatin
JP2006248978A (ja) 2005-03-10 2006-09-21 Mebiopharm Co Ltd 新規なリポソーム製剤
AU2005329764B2 (en) * 2005-03-28 2010-08-12 Dabur Pharma Ltd. Stable pharmaceutical compositions of platinum (II) antitumour agents
US7605282B2 (en) * 2005-04-09 2009-10-20 Vuab Pharma A.S. Process for the preparation of an oxaliplatin preparation
DE102005038347A1 (de) * 2005-08-11 2007-02-15 Hexal Ag Herstellung einer Oxaliplatin-Lösung und Behälter sowie Behälter-Set mit der Lösung
WO2007029268A2 (en) * 2005-09-05 2007-03-15 Dabur Pharma Limited Stable oxaliplatin formulation
EP1979369A1 (en) 2006-01-30 2008-10-15 Platco Technologies (Proprietary) Limited Preparation of platinum (ll) complexes
KR100913063B1 (ko) 2006-09-13 2009-08-21 주식회사유한양행 옥살리플라틴-함유 주사용 용액
EP2124886A2 (en) * 2007-01-22 2009-12-02 Pliva-Lachema A.S. Oxaliplatin pharmaceutical composition with alcoholic sugar-based buffer
US20100267824A1 (en) * 2007-11-12 2010-10-21 Intas Pharmaceuticals Limited Stable oxaliplatin composition for parenteral administration
US20090130017A1 (en) * 2007-11-19 2009-05-21 Searete Llc Targeted short-lived drug delivery
WO2010056847A2 (en) * 2008-11-13 2010-05-20 Taigen Biotechnology Co., Ltd. Lyophilization formulation
CN101461801B (zh) * 2008-12-26 2013-05-15 辰欣药业股份有限公司 一种奥沙利铂药物组合物及其制备方法
WO2011034394A2 (ko) 2009-09-21 2011-03-24 주식회사 중외제약 옥살리플라틴의 나노 입자 및 이를 제조하는 방법
CN102274171A (zh) * 2011-08-04 2011-12-14 上海希迪制药有限公司 一种奥沙利铂注射剂
CN104523674B (zh) * 2014-12-11 2017-10-24 广州市上为医药科技有限公司 一种以奥沙利铂为主药成分的注射用组合物
KR101683635B1 (ko) * 2014-12-29 2016-12-09 가천대학교 산학협력단 락테이트 금속염을 포함하는 암 치료용 약학 조성물
CN104829653B (zh) * 2015-05-06 2016-03-23 山东罗欣药业集团股份有限公司 一种奥沙利铂水合物晶体及其冻干粉针剂
US10751365B2 (en) 2018-01-12 2020-08-25 Metimedi Pharmaceuticals Co., Ltd. Methods of treating chronic inflammatory diseases

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6041077B2 (ja) * 1976-09-06 1985-09-13 喜徳 喜谷 １，２‐ジアミノシクロヘキサン異性体のシス白金（２）錯体
PT93772A (pt) 1989-04-17 1991-01-08 Searle & Co Processo para a preparacao de composicoes para o tratamento de neoplasias, contendo um agente anti-neoplastico, por exemplo doxorubicina e um agente protector para reduzir os efeitos secundarios, por exemplo carbetimer
EP0464210A4 (en) 1989-12-15 1992-11-25 Tsumura & Co. Novel platinum complex and antitumor drug containing the same as active ingredient
JPH04185601A (ja) * 1990-11-20 1992-07-02 Unitika Ltd 白金抗癌剤徐放性製剤
ATE247471T1 (de) * 1991-11-15 2003-09-15 Smithkline Beecham Corp Cisplatin und topotecan enthaltende zusammensetzung als antitumor.
JPH0776230B2 (ja) * 1992-01-13 1995-08-16 田中貴金属工業株式会社 白金化合物の製造方法
JPH05238936A (ja) 1992-02-27 1993-09-17 Dainippon Pharmaceut Co Ltd カルシトリオールの水性液剤
JP2673331B2 (ja) * 1993-01-12 1997-11-05 田中貴金属工業 株式会社 光学的に高純度なシス―オキザラート（トランス―１―１，２―シクロヘキサンジアミン）白金（▲ｉｉ▼）
JPH06287021A (ja) * 1992-04-22 1994-10-11 Tanaka Kikinzoku Kogyo Kk 光学活性な白金錯化合物の光学的分割方法
AU5416394A (en) * 1992-11-24 1994-06-22 Debiopharm S.A. Cisplatinum/oxaliplatinum combination
JP3025602B2 (ja) * 1993-05-21 2000-03-27 デビオファーム エス．アー． 光学的に高純度なシス−オキザラート（トランス−ｌ−１，２−シクロヘキサンジアミン）白金（ＩＩ）錯体の製造方法
US5455270A (en) * 1993-08-11 1995-10-03 Bristol-Myers Squibb Co. Stabilized solutions of platinum(II) antitumor agents
CZ286714B6 (en) 1994-08-08 2000-06-14 Debiopharm Sa Pharmaceutically stable preparation based on oxaliplatinum
DE69531722T2 (de) * 1994-11-11 2004-07-01 Debiopharm S.A. Karzinostatische Zusammensetzungen, welche Cis-Oxaliplatin und eine oder mehrere andere verträgliche Karzinostatika enthalten
FR2740686B1 (fr) * 1995-11-03 1998-01-16 Sanofi Sa Formulation pharmaceutique lyophilisee stable
EP0801070B1 (en) 1996-04-10 2003-04-16 Debiopharm S.A. Process of preparing platinum compound
JPH09294809A (ja) 1996-05-07 1997-11-18 Terumo Corp 薬液注入器具
GB9804013D0 (en) 1998-02-25 1998-04-22 Sanofi Sa Formulations

Also Published As

Publication number Publication date
ES2161085T3 (es) 2001-11-16
DE69900162D1 (de) 2001-08-02
JP2002504524A (ja) 2002-02-12
CA2261500C (en) 2001-07-17
GT199900019A (es) 2000-08-04
NO20004240L (no) 2000-10-18
PL197948B1 (pl) 2008-05-30
EP0943331A3 (en) 1999-11-03
WO1999043355A2 (en) 1999-09-02
PL343021A1 (en) 2001-07-30
UA70316C2 (uk) 2004-10-15
CZ302196B6 (cs) 2010-12-15
DK0943331T3 (da) 2001-10-15
CN1152718C (zh) 2004-06-09
HUP0103707A2 (hu) 2002-02-28
HK1036405A1 (en) 2002-01-04
ZA991489B (en) 1999-09-30
DE69900162T2 (de) 2002-04-18
EP0943331A2 (en) 1999-09-22
AR015524A1 (es) 2001-05-02
CZ20003089A3 (cs) 2000-12-13
ATE202472T1 (de) 2001-07-15
US6306902B1 (en) 2001-10-23
JP4430229B2 (ja) 2010-03-10
PT943331E (pt) 2001-12-28
GB9804013D0 (en) 1998-04-22
HU224611B1 (hu) 2005-11-28
GR3036646T3 (en) 2001-12-31
NO20004240D0 (no) 2000-08-24
EP0943331B1 (en) 2001-06-27
CN1291886A (zh) 2001-04-18
WO1999043355A3 (en) 1999-11-04
AU2632499A (en) 1999-09-15
RU2207857C2 (ru) 2003-07-10
AU757101B2 (en) 2003-01-30
MXPA00008195A (es) 2004-11-22
IL137772A (en) 2006-04-10
CA2261500A1 (en) 1999-08-25
NO329900B1 (no) 2011-01-24
KR20010041182A (ko) 2001-05-15
HUP0103707A3 (en) 2004-07-28

Similar Documents

Publication Publication Date Title
BR9908273A (pt) Formulações
DK0915898T3 (da) Krystalform I af clarithromycin
PT1143967E (pt) Utilizacao de derivados anticonvulsivos para o tratamento de cefaleias em salvas
BR9909844A (pt) Processo para sintetizar um composto, e, composto.
EP1024145A3 (en) Novel azalides and methods of making same
YU23102A (sh) Jedinjenja za lečenje ishemije
BR9915822A (pt) Derivados de pirazolopirimidinona para o tratamento de impotência
EA200100154A1 (ru) Бензоциклогептены, способ их получения, содержащие их фармацевтические препараты и их применение для получения лекарственных средств
BR0109780A (pt) Soluções de ácido ascórbico estabilizadas; uso das mesmas; processo para sua obtenção e formulações compreendendo as mesmas
DE60021381D1 (de) Chinonverbindungen zur behandlung von krankheiten
EE200000472A (et) Kasvajavastased toimeained
EP0992509A3 (en) Novel macrolide derivatives
AU5173501A (en) Polyamine analogues as cytotoxic agents
DK1207870T3 (da) Farmaceutiske præparater, der indeholder N-palmitoylethanolamid og anvendelse deraf
HUP0003219A3 (en) Phthalazine derivatives, process for producing them and pharmaceutical compositions containing them and use of the compounds for producing pharmaceutical compositions useful for treating erectile dysfunction
MXPA02007903A (es) Uso de acido 2-metil-tiazolidina-2, 4-dicarboxilico (2-mtdc) y/o sales fisiologicamente compatibles para tratar y/o prevenir canceres.
BG105204A (en) Salts of paroxetine
EA200000172A2 (ru) Способ получения стимуляторов секреции гормонов роста
ID27440A (id) Proses untuk menyiapkan penengah-penengah
SE9902742D0 (sv) New pharmaceutical formultion
BR9906821A (pt) Composição farmacêutica e processo para melhorar a discinesia induzida por levodopa e discinesia tardia, e, uso de riluzol para a preparação de uma composição farmacêutica
EP1574507A3 (en) Furo- and pyrano-naphthoquinones and their use in the treatment of cancer
BR9908838A (pt) Uso de um glicocorticóide, processeo para tratar glomerulonefrite aguda ou crÈnica, e, composição farmacêutica para tratar glomerulonefrite
HK1050203A1 (en) Novel fusidic acid derivatives.
MD457G2 (ro) Derivaţi noi de naftiridină, procedeu de preparare a lor, compoziţii farmaceutice care le conţin, utilizarea lor ca medicamente de antireproducere

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFERIMENTO DO PRESENTE PEDIDO, COM BASE NOS ARTIGOS 8O, 13 E 25 DA LPI

B12B Appeal against refusal [chapter 12.2 patent gazette]